The add-on, called RxPass, will allow Prime members to get as many drugs as they need from a list of 50 generic medications used to treat common conditions.

Sweden and Finland have worked to try and improve their relations with Turkey, but recent events have thrown fresh wrenches into any hopes for progress.

U.S. stocks have fallen far short of their global peers over the past three months, a rarity in recent years, and analysts expect this divergence to widen over the course of 2023.

The D.C. Court of Appeals has scheduled a date to hear oral arguments in Grayscale’s lawsuit contesting the SEC’s decision to deny the conversion of GBTC to an ETF.

Two European stocks on the list stand out for having a negative debt-to-equity ratio and potential upside of around 20%.

Russia has been largely isolated from the global stage following its brutal invasion of Ukraine. And yet, the international community continues to engage with other countries accused of gross human rights abuses. That begs the question: what does it take to be labeled a pariah state, and who gets to decide?

Google executives held a town hall meeting with staffers on Monday after the company announced its largest layoff in history.

The San Mateo County Sheriff’s Office said it took a 67-year-old suspect into custody without incident.

Goldman Sachs, Morgan Stanley and others all name one Chinese tech name as a top pick.

Investors looking to outperform right now may want to consider these types of U.S. stocks, according to a strategist at Goldman Sachs Asset Management.